Univercells Technologies, part of the Donaldson Life Sciences, is a global provider of innovative biomanufacturing technologies, specializing in the development and production of advanced bioreactors. These cutting-edge bioreactors are designed to achieve cost-effective viral production from R&D to commercial scales. By leveraging the strengths of process intensification and chaining, the company addresses the growing demand for viral vectors and viral vaccines. Univercells Technologies is committed to helping customers increase performance with minimized footprint and costs, while anticipating future needs. 

Incorporated in Belgium in 2020, Univercells Technologies is now a part of Donaldson Company (NYSE: DCI).  

Have the initiative, drive, and desire to make a difference by joining Univercells Technologies? Explore our job openings today on our Donaldson global career website for all our open vacancies.